BECOME MEMBER SUPPORT
Year Cancer type Speaker
Breast Cancer Updates 2021 - 18th Dec
Optimising Treatment Strategies in Neoadjuvant Treatment of HER2+ eBC
New Paradigm Approach in Treatment of PDL1+ mTNBC with Tecentriq
New Advant for kadcyla in treatment of HER2+ Residual Disease
Video and slides 
CRSF Asco list of publications 
Ongoing studies 